View all cases
UPC CFI 315/2024
Jun 13, 2024·EP3756767 Unitary patent · MODULAR POINT-OF-CARE DEVICES AND USES THEREOF
- Case details
- StatusCase Closed (No infringement)ActionInfringementCategoryMain infringement action
- Parties
- ClaimantsRepresentatives
- Christof Höhne-EIP Europe LLP
- Sebastian Fuchs-EIP Europe LLP
- Matthew Blaseby-EIP Europe LLP
- Darren Smyth-EIP Europe LLP
Respondents- bioMérieux SAOperating co.
- bioMérieux Deutschland GmbHOperating co.
- bioMérieux Italia S.p.A.Operating co.
- bioMérieux Austria GmbHOperating co.
- bioMérieux Portugal, Lda.Operating co.
- bioMérieux Benelux BVOperating co.
Representatives- Benjamin Husband-Carpmaels & Ransford
- Agathe Michel-De Cazotte-Carpmaels & Ransford
- Division
- Dusseldorf LD
- Technology
- InstrumentsMeasurement · Analysis of biological materials
- ChemistryChemical engineering
- Language
- English
- First decided
- Sep 26, 2025
- Last decision
- Jan 28, 2026
- EPO Opposition
- bioMérieux société anonyme (SA)Admissible2025-01-31
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
| Infringement found | Median days to first decision | |
|---|---|---|
| All UPC | 53% (62/117) | 124 |
| Dusseldorf LD | Locked | Locked |
| Judge Ronny Thomas | Locked | Locked |
| Judge Berenice Thom | Locked | Locked |
| Judge Mélanie Bessaud | Locked | Locked |
| Judge Michel Abello | Locked | Locked |
At the UPC: Labrador Diagnostics LLC (7 cases)·bioMérieux Group (12 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 4 other proceedings
UPC CoA 47/2026·UPC CoA 937/2025·UPC CFI 571/2024·CC 54050/2024
2 other defendants litigating the same or a related patent
Start a free trial to see how each one ended.
More cases: Dusseldorf LD·2024
Decisions
- 2026-01-28Infringement ActionPublic
Summary: The Düsseldorf Local Division dismissed Labrador Diagnostics' infringement action concerning EP 3 756 767 against bioMérieux entities, finding no infringement after the Central Division amended the patent claims; the court was bound by the amended claim wording and validity was no longer decisive.
Show the legal issues (3)
- Bifurcation — Local Division bound by Central Division's amended claims
- Non-infringement of amended claims
- Claim construction (equivalence)
- 2025-09-26Procedural OrderPublic
Summary: The Düsseldorf Local Division issued a procedural order under R. 108 RoP in the infringement action by Labrador Diagnostics LLC against bioMérieux entities concerning EP 3 756 767 B1 (diagnostic testing apparatus).
Show the legal issues (2)
- Scheduling (R. 108 RoP)
- Diagnostic testing apparatus infringement
- 2025-04-23
Summary: The Düsseldorf Local Division referred the counterclaim for revocation to the Milan Central Division while retaining jurisdiction over the infringement action pursuant to Art. 33(3)(b) UPCA. The application to amend the patent was referred together with the counterclaim for revocation.
Show the legal issues (4)
- Bifurcation
- Referral of revocation counterclaim to Central Division
- Art. 33(3)(b) UPCA
- Application to amend patent
Documents
| Document title | Date | Public |
|---|---|---|
| Case closed | 2026-03-02 | Not public |
| Communication | 2026-03-02 | Not public |
| Receipt | 2026-03-02 | Not public |
| Cover sheet | 2026-03-02 | Not public |
| Application Respondent | 2026-03-02 | Not public |
| Application Respondent | 2026-03-02 | Not public |
| Decision | 2026-01-28 | Not public |
| Decision | 2026-01-28 | Public |
| Order | 2026-01-10 | Not public |
| Order | 2026-01-10 | Not public |
| Other Documents | 2025-12-22 | Not public |
| Order | 2025-11-26 | Not public |
| Order | 2025-11-26 | Not public |
| Oral procedure opened | 2025-11-26 | Not public |
| Cover sheet | 2025-11-26 | Not public |
| Application document Claimant | 2025-11-26 | Not public |
| Receipt | 2025-11-26 | Not public |
| Cover sheet | 2025-11-26 | Not public |
| Other document Claimant | 2025-11-26 | Not public |
| Receipt | 2025-11-26 | Not public |
| Cover sheet | 2025-11-26 | Not public |
| Other document Defendant | 2025-11-26 | Not public |
| Receipt | 2025-11-26 | Not public |
| Interim procedure closed | 2025-11-24 | Not public |
| Other Documents | 2025-11-24 | Not public |
| Interim procedure opened | 2025-11-20 | Not public |
| Other Documents | 2025-11-20 | Not public |
| Cover sheet | 2025-11-20 | Not public |
| Other document Claimant | 2025-11-20 | Not public |
| Receipt | 2025-11-20 | Not public |
| Cover sheet | 2025-11-17 | Not public |
| Other document Defendant | 2025-11-17 | Not public |
| Other document Defendant | 2025-11-17 | Not public |
| Receipt | 2025-11-17 | Not public |
| Cover sheet | 2025-11-06 | Not public |
| Other document Defendant | 2025-11-06 | Not public |
| Receipt | 2025-11-06 | Not public |
| Cover sheet | 2025-11-06 | Not public |
| Further pleadings | 2025-11-06 | Not public |
| Receipt | 2025-11-06 | Not public |
| Cover sheet | 2025-11-06 | Not public |
| Other document Claimant | 2025-11-06 | Not public |
| Exhibit document Claimant | 2025-11-06 | Not public |
| Other document Claimant | 2025-11-06 | Not public |
| Receipt | 2025-11-06 | Not public |
| Communication | 2025-11-04 | Not public |
| Cover sheet | 2025-10-30 | Not public |
| Further pleadings | 2025-10-30 | Not public |
| Exhibit document Defendant | 2025-10-30 | Not public |
| Receipt | 2025-10-30 | Not public |
| Cover sheet | 2025-10-30 | Not public |
| Further pleadings | 2025-10-30 | Not public |
| Exhibit document Claimant | 2025-10-30 | Not public |
| Exhibit document Claimant | 2025-10-30 | Not public |
| Other document Claimant | 2025-10-30 | Not public |
| Receipt | 2025-10-30 | Not public |
| Order | 2025-10-23 | Not public |
| Order | 2025-10-23 | Not public |
| Cover sheet | 2025-10-09 | Not public |
| Other document | 2025-10-09 | Not public |
| Receipt | 2025-10-09 | Not public |
| Summons to oral hearing | 2025-09-26 | Not public |
| Summons | 2025-09-26 | Not public |
| Hearing-Dates | 2025-04-23 | Not public |
| R. 28 RoP - Set a date and time for the oral hearing | 2025-04-23 | Public |
| Opportunity to comment | 2025-04-04 | Not public |
| Panel-Appointment | 2025-02-26 | Not public |
| 20250224_ACT_35332.2024EIP Submission | 2025-02-24 | Not public |
| Exhibit EIP 20 | 2025-02-24 | Not public |
| Schedule Oral Hearing | 2025-02-21 | Not public |
| Hearing-Dates | 2025-02-21 | Not public |
| Receipt | 2025-02-03 | Not public |
| CR-Inf 35 | 2025-01-31 | Not public |
| 2025.01.31 - Rule 9 Application (Infringement) | 2025-01-31 | Not public |
| Acknowledgement-of-lodging | 2025-01-29 | Not public |
| CR-Inf 29 | 2025-01-29 | Not public |
| CR-Inf 31 (part one) | 2025-01-29 | Not public |
| CR-Inf 26 | 2025-01-29 | Not public |
| CR-Inf 28a | 2025-01-29 | Not public |
| CR-Inf 31 (part two) | 2025-01-29 | Not public |
| CR-Inf 31 (part three) | 2025-01-29 | Not public |
| CR-Inf 32 | 2025-01-29 | Not public |
| CR-Inf 30 | 2025-01-29 | Not public |
| 2025.01.29 - Rejoinder to the Reply to the SoD - signed | 2025-01-29 | Not public |
| CR-Inf 27a | 2025-01-29 | Not public |
| CR-Inf 28 | 2025-01-29 | Not public |
| CR-Inf 34 | 2025-01-29 | Not public |
| CR-Inf 27 | 2025-01-29 | Not public |
| CR-Inf 33 | 2025-01-29 | Not public |
| Acknowledgement-of-lodging | 2025-01-29 | Not public |
| CR-Inf 31 (part two) | 2025-01-29 | Not public |
| CR-Inf 31 (part one) | 2025-01-29 | Not public |
| CR-Inf 33 | 2025-01-29 | Not public |
| CR-Inf 34 | 2025-01-29 | Not public |
| CR-Inf 28 | 2025-01-29 | Not public |
| CR-Inf 27 | 2025-01-29 | Not public |
| 2025.01.29 - Rejoinder to the Reply to the SoD - signed | 2025-01-29 | Not public |
| CR-Inf 28a | 2025-01-29 | Not public |
| CR-Inf 31 (part three) | 2025-01-29 | Not public |
| CR-Inf 29 | 2025-01-29 | Not public |
| CR-Inf 27a | 2025-01-29 | Not public |
| CR-Inf 26 | 2025-01-29 | Not public |
| CR-Inf 30 | 2025-01-29 | Not public |
| CR-Inf 32 | 2025-01-29 | Not public |
| Acknowledgement-of-lodging | 2025-01-29 | Not public |
| CR-Inf 26 | 2025-01-29 | Not public |
| CR-Inf 34 | 2025-01-29 | Not public |
| CR-Inf 31 (part three) | 2025-01-29 | Not public |
| CR-Inf 31 (part two) | 2025-01-29 | Not public |
| CR-Inf 27a | 2025-01-29 | Not public |
| CR-Inf 31 (part one) | 2025-01-29 | Not public |
| CR-Inf 29 | 2025-01-29 | Not public |
| CR-Inf 33 | 2025-01-29 | Not public |
| CR-Inf 30 | 2025-01-29 | Not public |
| CR-Inf 32 | 2025-01-29 | Not public |
| CR-Inf 28a | 2025-01-29 | Not public |
| CR-Inf 28 | 2025-01-29 | Not public |
| 2025.01.29 - Rejoinder to the Reply to the SoD - signed | 2025-01-29 | Not public |
| CR-Inf 27 | 2025-01-29 | Not public |
| Acknowledgement-of-lodging | 2025-01-29 | Not public |
| CR-Inf 27a | 2025-01-29 | Not public |
| CR-Inf 31 (part two) | 2025-01-29 | Not public |
| CR-Inf 29 | 2025-01-29 | Not public |
| CR-Inf 33 | 2025-01-29 | Not public |
| CR-Inf 28 | 2025-01-29 | Not public |
| CR-Inf 26 | 2025-01-29 | Not public |
| CR-Inf 28a | 2025-01-29 | Not public |
| CR-Inf 31 (part three) | 2025-01-29 | Not public |
| CR-Inf 27 | 2025-01-29 | Not public |
| 2025.01.29 - Rejoinder to the Reply to the SoD - signed | 2025-01-29 | Not public |
| CR-Inf 31 (part one) | 2025-01-29 | Not public |
| CR-Inf 30 | 2025-01-29 | Not public |
| CR-Inf 32 | 2025-01-29 | Not public |
| CR-Inf 34 | 2025-01-29 | Not public |
| Acknowledgement-of-lodging | 2025-01-29 | Not public |
| CR-Inf 30 | 2025-01-29 | Not public |
| CR-Inf 29 | 2025-01-29 | Not public |
| CR-Inf 28a | 2025-01-29 | Not public |
| CR-Inf 33 | 2025-01-29 | Not public |
| CR-Inf 27 | 2025-01-29 | Not public |
| CR-Inf 34 | 2025-01-29 | Not public |
| CR-Inf 26 | 2025-01-29 | Not public |
| 2025.01.29 - Rejoinder to the Reply to the SoD - signed | 2025-01-29 | Not public |
| CR-Inf 31 (part three) | 2025-01-29 | Not public |
| CR-Inf 28 | 2025-01-29 | Not public |
| CR-Inf 27a | 2025-01-29 | Not public |
| CR-Inf 31 (part one) | 2025-01-29 | Not public |
| CR-Inf 32 | 2025-01-29 | Not public |
| CR-Inf 31 (part two) | 2025-01-29 | Not public |
| Acknowledgement-of-lodging | 2025-01-29 | Not public |
| CR-Inf 26 | 2025-01-29 | Not public |
| CR-Inf 30 | 2025-01-29 | Not public |
| CR-Inf 31 (part two) | 2025-01-29 | Not public |
| CR-Inf 33 | 2025-01-29 | Not public |
| 2025.01.29 - Rejoinder to the Reply to the SoD - signed | 2025-01-29 | Not public |
| CR-Inf 29 | 2025-01-29 | Not public |
| CR-Inf 34 | 2025-01-29 | Not public |
| CR-Inf 31 (part one) | 2025-01-29 | Not public |
| CR-Inf 28 | 2025-01-29 | Not public |
| CR-Inf 28a | 2025-01-29 | Not public |
| CR-Inf 31 (part three) | 2025-01-29 | Not public |
| CR-Inf 27 | 2025-01-29 | Not public |
| CR-Inf 27a | 2025-01-29 | Not public |
| CR-Inf 32 | 2025-01-29 | Not public |
| Acknowledgement-of-lodging | 2024-11-29 | Not public |
| Acknowledgement-of-lodging | 2024-11-29 | Not public |
| Acknowledgement-of-lodging | 2024-11-29 | Not public |
| Acknowledgement-of-lodging | 2024-11-29 | Not public |
| Acknowledgement-of-lodging | 2024-11-29 | Not public |
| Acknowledgement-of-lodging | 2024-11-29 | Not public |
| 20241029_35332.2024_CC_54050.2024_EIP_Reply to Statement of Defence | 2024-11-29 | Not public |
| 20241029_35332.2024_CC_54050.2024_EIP_Reply to Statement of Defence | 2024-11-29 | Not public |
| 20241029_35332.2024_CC_54050.2024_EIP_Reply to Statement of Defence | 2024-11-29 | Not public |
| 20241029_35332.2024_CC_54050.2024_EIP_Reply to Statement of Defence | 2024-11-29 | Not public |
| 20241029_35332.2024_CC_54050.2024_EIP_Reply to Statement of Defence | 2024-11-29 | Not public |
| Exhibit_EIP_12a | 2024-11-29 | Not public |
| Exhibit_EIP_17 | 2024-11-29 | Not public |
| Exhibit EIP 14 | 2024-11-29 | Not public |
| Exhibit_EIP_16 | 2024-11-29 | Not public |
| Exhibit_EIP_13 | 2024-11-29 | Not public |
| Exhibit EIP 12 | 2024-11-29 | Not public |
| Exhibit_EIP_15 | 2024-11-29 | Not public |
| Exhibit EIP 18 | 2024-11-29 | Not public |
| Exhibit EIP 19 | 2024-11-29 | Not public |
| 20241029_35332.2024_EIP_Reply to Statement of Defence | 2024-11-29 | Not public |
| Panel-Appointment | 2024-10-21 | Not public |
| Closure of the workflow | 2024-10-16 | Public |
| Outcome of the Order | 2024-10-16 | Not public |
| R. 33 RoP Order | 2024-10-16 | Public |
| Comment to technically qualified judge | 2024-10-14 | Not public |
| Opportunity to comment | 2024-10-01 | Not public |
| Receipt | 2024-10-01 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-10-01 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-10-01 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-10-01 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-10-01 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-10-01 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-10-01 | Not public |
| Acknowledgement-of-lodging | 2024-09-30 | Not public |
| CR-Inf 4 | 2024-09-30 | Not public |
| CR-Inf 5 | 2024-09-30 | Not public |
| CR-Inf 11 | 2024-09-30 | Not public |
| CR-Inf 17 | 2024-09-30 | Not public |
| Statement of Defence SIGNED | 2024-09-30 | Not public |
| CR-Inf 22a (part 2) | 2024-09-30 | Not public |
| CR-Inf 10 | 2024-09-30 | Not public |
| CR-Inf 13 | 2024-09-30 | Not public |
| CR-Inf 6 | 2024-09-30 | Not public |
| CR-Inf 22a (part 1) | 2024-09-30 | Not public |
| CR-Inf 16 | 2024-09-30 | Not public |
| CR-Inf 1 | 2024-09-30 | Not public |
| CR-Inf 24 | 2024-09-30 | Not public |
| CR-Inf 3 | 2024-09-30 | Not public |
| CR-Inf 8 | 2024-09-30 | Not public |
| CR-Inf 18 | 2024-09-30 | Not public |
| CR-Inf 21 (part 2) | 2024-09-30 | Not public |
| CR-Inf 22b | 2024-09-30 | Not public |
| CR-Inf 22e | 2024-09-30 | Not public |
| CR-Inf 22 | 2024-09-30 | Not public |
| CR-Inf 20 | 2024-09-30 | Not public |
| CR-Inf 25 | 2024-09-30 | Not public |
| CR-Inf 12 | 2024-09-30 | Not public |
| CR-Inf 7 | 2024-09-30 | Not public |
| CR-Inf 23 | 2024-09-30 | Not public |
| CR-Inf 22d | 2024-09-30 | Not public |
| CR-Inf 14 | 2024-09-30 | Not public |
| CR-Inf 22c | 2024-09-30 | Not public |
| CR-Inf 15 | 2024-09-30 | Not public |
| CR-Inf 2 | 2024-09-30 | Not public |
| CR-Inf 21 (part 1) | 2024-09-30 | Not public |
| CR-Inf 9 | 2024-09-30 | Not public |
| CR-Inf 19 | 2024-09-30 | Not public |
| Acknowledgement-of-lodging | 2024-09-30 | Not public |
| Statement of Defence SIGNED | 2024-09-30 | Not public |
| CR-Inf 15 | 2024-09-30 | Not public |
| CR-Inf 12 | 2024-09-30 | Not public |
| CR-Inf 3 | 2024-09-30 | Not public |
| CR-Inf 21 (part 2) | 2024-09-30 | Not public |
| CR-Inf 18 | 2024-09-30 | Not public |
| CR-Inf 25 | 2024-09-30 | Not public |
| CR-Inf 16 | 2024-09-30 | Not public |
| CR-Inf 13 | 2024-09-30 | Not public |
| CR-Inf 22d | 2024-09-30 | Not public |
| CR-Inf 21 (part 1) | 2024-09-30 | Not public |
| CR-Inf 8 | 2024-09-30 | Not public |
| CR-Inf 24 | 2024-09-30 | Not public |
| CR-Inf 22e | 2024-09-30 | Not public |
| CR-Inf 22c | 2024-09-30 | Not public |
| CR-Inf 19 | 2024-09-30 | Not public |
| CR-Inf 2 | 2024-09-30 | Not public |
| CR-Inf 23 | 2024-09-30 | Not public |
| CR-Inf 20 | 2024-09-30 | Not public |
| CR-Inf 1 | 2024-09-30 | Not public |
| CR-Inf 7 | 2024-09-30 | Not public |
| CR-Inf 10 | 2024-09-30 | Not public |
| CR-Inf 6 | 2024-09-30 | Not public |
| CR-Inf 9 | 2024-09-30 | Not public |
| CR-Inf 22 | 2024-09-30 | Not public |
| CR-Inf 11 | 2024-09-30 | Not public |
| CR-Inf 17 | 2024-09-30 | Not public |
| CR-Inf 22b | 2024-09-30 | Not public |
| CR-Inf 22a (part 2) | 2024-09-30 | Not public |
| CR-Inf 5 | 2024-09-30 | Not public |
| CR-Inf 14 | 2024-09-30 | Not public |
| CR-Inf 22a (part 1) | 2024-09-30 | Not public |
| CR-Inf 4 | 2024-09-30 | Not public |
| Acknowledgement-of-lodging | 2024-09-30 | Not public |
| CR-Inf 18 | 2024-09-30 | Not public |
| CR-Inf 1 | 2024-09-30 | Not public |
| CR-Inf 23 | 2024-09-30 | Not public |
| CR-Inf 22b | 2024-09-30 | Not public |
| CR-Inf 6 | 2024-09-30 | Not public |
| CR-Inf 22 | 2024-09-30 | Not public |
| CR-Inf 22a (part 2) | 2024-09-30 | Not public |
| CR-Inf 2 | 2024-09-30 | Not public |
| CR-Inf 7 | 2024-09-30 | Not public |
| CR-Inf 9 | 2024-09-30 | Not public |
| CR-Inf 10 | 2024-09-30 | Not public |
| CR-Inf 14 | 2024-09-30 | Not public |
| CR-Inf 19 | 2024-09-30 | Not public |
| CR-Inf 8 | 2024-09-30 | Not public |
| CR-Inf 22a (part 1) | 2024-09-30 | Not public |
| Statement of Defence SIGNED | 2024-09-30 | Not public |
| CR-Inf 11 | 2024-09-30 | Not public |
| CR-Inf 16 | 2024-09-30 | Not public |
| CR-Inf 25 | 2024-09-30 | Not public |
| CR-Inf 22d | 2024-09-30 | Not public |
| CR-Inf 21 (part 2) | 2024-09-30 | Not public |
| CR-Inf 20 | 2024-09-30 | Not public |
| CR-Inf 4 | 2024-09-30 | Not public |
| CR-Inf 24 | 2024-09-30 | Not public |
| CR-Inf 22e | 2024-09-30 | Not public |
| CR-Inf 12 | 2024-09-30 | Not public |
| CR-Inf 3 | 2024-09-30 | Not public |
| CR-Inf 21 (part 1) | 2024-09-30 | Not public |
| CR-Inf 13 | 2024-09-30 | Not public |
| CR-Inf 15 | 2024-09-30 | Not public |
| CR-Inf 17 | 2024-09-30 | Not public |
| CR-Inf 5 | 2024-09-30 | Not public |
| CR-Inf 22c | 2024-09-30 | Not public |
| Acknowledgement-of-lodging | 2024-09-30 | Not public |
| CR-Inf 15 | 2024-09-30 | Not public |
| CR-Inf 1 | 2024-09-30 | Not public |
| CR-Inf 4 | 2024-09-30 | Not public |
| CR-Inf 22a (part 1) | 2024-09-30 | Not public |
| CR-Inf 12 | 2024-09-30 | Not public |
| CR-Inf 18 | 2024-09-30 | Not public |
| CR-Inf 19 | 2024-09-30 | Not public |
| CR-Inf 21 (part 1) | 2024-09-30 | Not public |
| CR-Inf 16 | 2024-09-30 | Not public |
| CR-Inf 9 | 2024-09-30 | Not public |
| CR-Inf 21 (part 2) | 2024-09-30 | Not public |
| CR-Inf 13 | 2024-09-30 | Not public |
| CR-Inf 20 | 2024-09-30 | Not public |
| CR-Inf 2 | 2024-09-30 | Not public |
| CR-Inf 10 | 2024-09-30 | Not public |
| CR-Inf 22d | 2024-09-30 | Not public |
| Statement of Defence SIGNED | 2024-09-30 | Not public |
| CR-Inf 17 | 2024-09-30 | Not public |
| CR-Inf 24 | 2024-09-30 | Not public |
| CR-Inf 22c | 2024-09-30 | Not public |
| CR-Inf 5 | 2024-09-30 | Not public |
| CR-Inf 22 | 2024-09-30 | Not public |
| CR-Inf 6 | 2024-09-30 | Not public |
| CR-Inf 23 | 2024-09-30 | Not public |
| CR-Inf 7 | 2024-09-30 | Not public |
| CR-Inf 25 | 2024-09-30 | Not public |
| CR-Inf 22a (part 2) | 2024-09-30 | Not public |
| CR-Inf 3 | 2024-09-30 | Not public |
| CR-Inf 14 | 2024-09-30 | Not public |
| CR-Inf 11 | 2024-09-30 | Not public |
| CR-Inf 22e | 2024-09-30 | Not public |
| CR-Inf 22b | 2024-09-30 | Not public |
| CR-Inf 8 | 2024-09-30 | Not public |
| Acknowledgement-of-lodging | 2024-09-30 | Not public |
| CR-Inf 5 | 2024-09-30 | Not public |
| CR-Inf 14 | 2024-09-30 | Not public |
| CR-Inf 4 | 2024-09-30 | Not public |
| CR-Inf 19 | 2024-09-30 | Not public |
| CR-Inf 21 (part 1) | 2024-09-30 | Not public |
| CR-Inf 16 | 2024-09-30 | Not public |
| CR-Inf 17 | 2024-09-30 | Not public |
| CR-Inf 2 | 2024-09-30 | Not public |
| Statement of Defence SIGNED | 2024-09-30 | Not public |
| CR-Inf 22c | 2024-09-30 | Not public |
| CR-Inf 18 | 2024-09-30 | Not public |
| CR-Inf 25 | 2024-09-30 | Not public |
| CR-Inf 22a (part 1) | 2024-09-30 | Not public |
| CR-Inf 13 | 2024-09-30 | Not public |
| CR-Inf 1 | 2024-09-30 | Not public |
| CR-Inf 22e | 2024-09-30 | Not public |
| CR-Inf 3 | 2024-09-30 | Not public |
| CR-Inf 23 | 2024-09-30 | Not public |
| CR-Inf 21 (part 2) | 2024-09-30 | Not public |
| CR-Inf 15 | 2024-09-30 | Not public |
| CR-Inf 24 | 2024-09-30 | Not public |
| CR-Inf 22a (part 2) | 2024-09-30 | Not public |
| CR-Inf 10 | 2024-09-30 | Not public |
| CR-Inf 22d | 2024-09-30 | Not public |
| CR-Inf 12 | 2024-09-30 | Not public |
| CR-Inf 22b | 2024-09-30 | Not public |
| CR-Inf 11 | 2024-09-30 | Not public |
| CR-Inf 8 | 2024-09-30 | Not public |
| CR-Inf 6 | 2024-09-30 | Not public |
| CR-Inf 9 | 2024-09-30 | Not public |
| CR-Inf 20 | 2024-09-30 | Not public |
| CR-Inf 22 | 2024-09-30 | Not public |
| CR-Inf 7 | 2024-09-30 | Not public |
| Acknowledgement-of-lodging | 2024-09-30 | Not public |
| Application for allocation of a TQJ | 2024-09-30 | Not public |
| CR-Inf 21 (part 2) | 2024-09-30 | Not public |
| CR-Inf 19 | 2024-09-30 | Not public |
| CR-Inf 22a (part 2) | 2024-09-30 | Not public |
| CR-Inf 23 | 2024-09-30 | Not public |
| CR-Inf 22 | 2024-09-30 | Not public |
| CR-Inf 22d | 2024-09-30 | Not public |
| CR-Inf 22a (part 1) | 2024-09-30 | Not public |
| CR-Inf 2 | 2024-09-30 | Not public |
| CR-Inf 14 | 2024-09-30 | Not public |
| CR-Inf 22c | 2024-09-30 | Not public |
| CR-Inf 4 | 2024-09-30 | Not public |
| CR-Inf 11 | 2024-09-30 | Not public |
| CR-Inf 6 | 2024-09-30 | Not public |
| CR-Inf 17 | 2024-09-30 | Not public |
| CR-Inf 15 | 2024-09-30 | Not public |
| CR-Inf 22e | 2024-09-30 | Not public |
| Statement of Defence SIGNED | 2024-09-30 | Not public |
| CR-Inf 25 | 2024-09-30 | Not public |
| CR-Inf 1 | 2024-09-30 | Not public |
| CR-Inf 18 | 2024-09-30 | Not public |
| CR-Inf 22b | 2024-09-30 | Not public |
| CR-Inf 3 | 2024-09-30 | Not public |
| CR-Inf 10 | 2024-09-30 | Not public |
| CR-Inf 20 | 2024-09-30 | Not public |
| CR-Inf 24 | 2024-09-30 | Not public |
| CR-Inf 13 | 2024-09-30 | Not public |
| CR-Inf 5 | 2024-09-30 | Not public |
| CR-Inf 16 | 2024-09-30 | Not public |
| CR-Inf 12 | 2024-09-30 | Not public |
| CR-Inf 9 | 2024-09-30 | Not public |
| CR-Inf 8 | 2024-09-30 | Not public |
| CR-Inf 7 | 2024-09-30 | Not public |
| CR-Inf 21 (part 1) | 2024-09-30 | Not public |
| Acknowledgement of access to case | 2024-07-09 | Not public |
| Acknowledgement of access to case | 2024-07-09 | Not public |
| Acknowledgement of access to case | 2024-07-09 | Not public |
| Acknowledgement of access to case | 2024-07-09 | Not public |
| Acknowledgement of access to case | 2024-07-09 | Not public |
| Acknowledgement of access to case | 2024-07-08 | Not public |
| Notification Of Service | 2024-07-05 | Not public |
| Confirmation of service_B6 | 2024-07-05 | Not public |
| Notification Of Service | 2024-07-05 | Not public |
| Confirmation of service | 2024-07-05 | Not public |
| Confirmation of service | 2024-07-05 | Not public |
| Notification Of Service | 2024-07-05 | Not public |
| Notification Of Service | 2024-07-05 | Not public |
| Confirmation of service | 2024-07-05 | Not public |
| Notification Of Service | 2024-07-05 | Not public |
| Confirmation of service | 2024-07-05 | Not public |
| Notification Of Service | 2024-07-05 | Not public |
| Confirmation of Service_B1 | 2024-07-05 | Not public |
| epoUploadDocumentsWorkflow | 2024-06-20 | Not public |
| Document from EPO | 2024-06-19 | Not public |
| Letter for Service | 2024-06-17 | Not public |
| Letter for Service | 2024-06-17 | Not public |
| Letter for Service | 2024-06-17 | Not public |
| Letter for Service | 2024-06-17 | Not public |
| Letter for Service | 2024-06-17 | Not public |
| Letter for Service | 2024-06-17 | Not public |
| Panel-Appointment | 2024-06-17 | Not public |
| EPO-Request-for-case-pending | 2024-06-17 | Not public |
| Receipt | 2024-06-17 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-06-17 | Not public |
| Acknowledgement-of-lodging | 2024-06-14 | Not public |
| Application | 2024-06-14 | Not public |
| Acknowledgement-of-lodging | 2024-06-12 | Not public |
| Exhibit EIP 11 | 2024-06-12 | Not public |
| Exhibit EIP 9 | 2024-06-12 | Not public |
| Exhibit EIP 4 | 2024-06-12 | Not public |
| Exhibit EIP 6 | 2024-06-12 | Not public |
| Exhibit EIP 4 | 2024-06-12 | Not public |
| Exhibit EIP 9 | 2024-06-12 | Not public |
| Exhibit EIP 5 | 2024-06-12 | Not public |
| Exhibit EIP 3 | 2024-06-12 | Not public |
| Exhibit EIP 7 | 2024-06-12 | Not public |
| Exhibit EIP 10 | 2024-06-12 | Not public |
| Exhibit EIP 8 | 2024-06-12 | Not public |
| 240612_EIP_SoC | 2024-06-12 | Not public |
| Exhibit EIP 2 | 2024-06-12 | Not public |
| Exhibit EIP 1 | 2024-06-12 | Not public |
| Exhibit EIP 5 | 2024-06-12 | Not public |
Coverage: Partial.Reasoning extracted with partial coverage — some sections may be incomplete.
Plain-English summary
Labrador Diagnostics LLC (US) sued bioMérieux SA and related entities for infringement of EP 3 756 767 B1, a patent for a modular point-of-care diagnostic testing device. After the Central Division amended the patent in parallel validity proceedings, the Düsseldorf Local Division dismissed Labrador's infringement action, holding it was bound by the amended claim wording under which the bioMérieux products did not infringe; the question of validity was no longer decisive once non-infringement was established.
Accepted arguments
What the court agreed with — by party.
Local Division is bound by the Central Division's amended claim wording in a bifurcated case
RespondentLegal basis: Art. 33 UPCA; bifurcation provisionsNote: Court held that once the Central Division amends the patent in the validity track, the Local Division in the infringement track must apply the new amended claims and cannot look behind them.
No infringement of amended claim 1: challenged products do not meet the amended claim features
RespondentLegal basis: Art. 25 UPCANote: Court dismissed the infringement action after construing the amended claims; the challenged bioMérieux products did not infringe.
Rejected arguments
What the court did not agree with — and why.
Infringement by equivalence of product claim 1 (challenged embodiment I)
ClaimantLegal basis: Art. 25(1) UPCAReason: Court left the admissibility of the doctrine of equivalents claim open as it was not decisive; non-infringement under the literal amended claim was sufficient to dismiss, and equivalence was not found.
Patent validity remains decisive for the infringement action even in a bifurcated case
ClaimantLegal basis: Art. 33 UPCAReason: In a bifurcated case where no infringement is found, validity is no longer decisive for the outcome of the infringement action.
Key legal principles
Doctrines and rules cited in the reasoning.
In a bifurcated UPC case, the Local Division is bound by the Central Division's amendment of the patent claimsWhere infringement is not found under amended claims, validity becomes irrelevant to the infringement actionDoctrine of equivalents admissibility question may be left open if non-infringement is found without itBifurcation: Local Division must apply amended claim wording from Central Division validity proceedings
Browse other cases on this principle.
Claim construction notes
The infringement action concerned EP 3 756 767 B1 (modular point-of-care diagnostic device). Following the Central Division's amendment of the patent in bifurcated proceedings, the Local Division applied the new amended claim wording and found that bioMérieux's challenged diagnostic systems did not meet the amended claim features. The precise scope of the amended claims is not detailed in the excerpt.